Condition: Locally Recurrent Prostate Cancer · Sponsor: Royal North Shore Hospital
To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.
This description comes directly from the study's public registry record.
Carolyn Kwong · +61 2 9463 1339 · carolyn.kwong@health.nsw.gov.au
Heidi Tsang · +61 2 9463 1340 · heidi.tsang@health.nsw.gov.au
Always discuss trial participation with your own doctor first.
| Royal North Shore Hospital | St Leonards, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03073278